Molecular Pharmacology, Vol 14, 1143-1147, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics

Prolonged Inhibition of DNA Synthesis Associated with the Accumulation of Methotrexate Polyglutamates by Cultured Human Cells

¹ The Medical Research Council Genetics Group and The Penny Cole Hematology Research Laboratory, McGill University-Montreal Children’s Hospital Research Institute, and Department of Pediatrics, McGill University Montreal, Quebec, Canada

Incubation of cultured human fibroblasts in 1 µM methotrexate results in a progressive accumulation of poly--glutamyl derivatives. This accumulation is not dependent on new protein synthesis. No polyglutamate derivatives are detectable until saturation by nonmetabolized methotrexate of a nonexchangeable intracellular fraction occurs. After saturation occurs both methotrexate and methotrexate polyglutamates are found in a freely-exchangeable and a non-exchangeable fraction. After saturation occurs all of the increase in the size of the nonexchangeable fraction is due to the accumulation of polyglutamates. Cells which have been incubated for up to 2 hr in 1 µM methotrexate rapidly regain the ability to incorporate deoxyuridine into DNA when transferred into methotrexate-free medium. With longer times of incubation resulting in the formation of longer and greater concentrations of polyglutamates, deoxyuridine incorporation is inhibited at least 24 h following transfer into methotrexate-free medium. In contrast, thymidine incorporation into DNA is increased over that seen in cells not incubated in methotrexate. We suggest that the metabolism of methotrexate in cultured human fibroblasts occurs according to the following steps: (i) saturation by nonmetabolized methotrexate of a nonexchangeable pool, (ii) addition of -glutamyl residues to methotrexate in a freely-exchangeable pool, (iii) appearance of methotrexate polyglutamates in a nonexchangeable pool. The inhibition of deoxyuridine incorporation in the absence of continued methotrexate may be due to the effects of previous sustained exposure to methotrexate, to the total quantity of methotrexate derivatives, or to some undefined differential effect of methotrexate polyglutamates.

Note:
ACKNOWLEDGMENTS We thank C. M. Baugh and M. G. Nair for the kind provision of methotrexate polyglutamates. We are also grateful to Huguette Ishmael and Lynne Prevost for assistance in the preparation of the manuscript.

This article has been cited by other articles:

				A. C. Racanelli, F. B. Turner, L.-Y. Xie, S. M. Taylor, and R. G. Moran A Mouse Gene That Coordinates Epigenetic Controls and Transcriptional Interference To Achieve Tissue-Specific Expression Mol. Cell. Biol., January 15, 2008; 28(2): 836 - 848. [Abstract] [Full Text] [PDF]

				Z.-S. Chen, R. W. Robey, M. G. Belinsky, I. Shchaveleva, X.-Q. Ren, Y. Sugimoto, D. D. Ross, S. E. Bates, and G. D. Kruh Transport of Methotrexate, Methotrexate Polyglutamates, and 17{beta}-Estradiol 17-({beta}-D-glucuronide) by ABCG2: Effects of Acquired Mutations at R482 on Methotrexate Transport Cancer Res., July 15, 2003; 63(14): 4048 - 4054. [Abstract] [Full Text] [PDF]

				H. Zeng, Z.-S. Chen, M. G. Belinsky, P. A. Rea, and G. D. Kruh Transport of Methotrexate (MTX) and Folates by Multidrug Resistance Protein (MRP) 3 and MRP1: Effect of Polyglutamylation on MTX Transport Cancer Res., October 1, 2001; 61(19): 7225 - 7232. [Abstract] [Full Text] [PDF]

				Y. G. Assaraf and I. D. Goldman Loss of Folic Acid Exporter Function with Markedly Augmented Folate Accumulation in Lipophilic Antifolate-resistant Mammalian Cells J. Biol. Chem., July 11, 1997; 272(28): 17460 - 17466. [Abstract] [Full Text] [PDF]